Pandemrix
Drug timelines are a Plus or Pro feature.
14 regulatory and trial events tracked for Pandemrix, covering 2009-12-04 to 2018-01-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™). [Phase 4]